A better definition of these mechanisms will be central to clarify the contribution of PARP1-dependent cell death to human pathology, particularly in a variety of neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, which are of rising concern in an aging human population. This evidence concerns the gene PARP1 and early-onset autosomal dominant Alzheimer disease.